Abstract
TCT-249 Remnant Cholesterol as a Residual Risk in Patients With Atherosclerotic Cardiovascular Disease Under Moderate-Intensity Statin With Ezetimibe Combination Therapy or High-Intensity Statin Monotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have